Larry Ramer

Larry Ramer

InvestorPlace Contributor

Larry Ramer has more than 15 years of experience in business journalism. He has worked for Globes, Israel’s most widely read business newspaper, as well as The Jerusalem Post and theflyonthewall.

Mr. Ramer’s expansive knowledge of politics enables him to provide valuable insights into how politics can affect stocks. He also focuses on contrary investing and specializes in the renewable energy and consumer discretionary sectors.

Among his highly successful, contrarian picks have been Super Micro Computer, Intel, and MGM Resorts.

You can reach him on StockTwits at @larryramer and learn more about his stock-picking record at his TipRanks profile.

Recent Articles

AMC’s Stock Sales Are Good for the Company and Bad for Shareholders

By Larry Ramer, InvestorPlace Contributor

AMC is unlikely to become profitable for the foreseeable future, and the "apes" probably won't be able to stop AMC stock from dropping tremendously.

Don’t Get Involved With the Company in Between; Avoid Churchill Capital Stock

By Larry Ramer, InvestorPlace Contributor

Between the high valuation of CCIV stock and the middle-of-the-pack status of Lucid Motors, the shares are unattractive.

BlackBerry Looks Like More Than Just a Meme Stock

By Larry Ramer, InvestorPlace Contributor

There's a great deal of evidence indicating that both institutional investors and retail investors are both buying BB stock.

5 Healthcare Stocks to Buy for Their Game-Changing Potential

By Larry Ramer, InvestorPlace Contributor

These healthcare stocks are at the forefront of huge trends, including precision medicine and advances in diagnosis technologies.

Why AT&T’s WarnerMedia Deal Bodes Badly for Disney Stock

By Larry Ramer, InvestorPlace Contributor

AT&T's apparent pessimism about the future of WarnerMedia spells trouble for DIS stock. Investors should sell Disney's shares.

4 Penny Stocks With the Potential to Become Top-Notch AI Players

By Larry Ramer, InvestorPlace Contributor

These four penny stocks could get a huge boost from the success of the underlying companies' AI systems going forward.

Bionano Stock Is Enticing on Strong Q1 Results and Saphyr’s Progress

By Larry Ramer, InvestorPlace Contributor

Demand for Bionano's Saphyr tool is climbing, while new, potentially life-saving uses are being found for it. BNGO stock remains a buy.

FDA’s Vaccine Attitude, New Data Don’t Bode Well for Ocugen Stock

By Larry Ramer, InvestorPlace Contributor

The FDA's recent warning that it could reject some applications for EUAs from vaccine makers does not portend well for Ocugen's aspirations. OCGN stock remains an excellent name to sell short.

Strong Data Center Demand Should Boost Plug Power Stock

By Larry Ramer, InvestorPlace Contributor

Green hydrogen appears to be a better backup power source for data centers than batteries. That's one of the positive catalysts of PLUG stock.

Why Airbnb Stock Is Not a Good Reopening Play

By Larry Ramer, InvestorPlace Contributor

Airbnb looks poised to be boosted less by the reopening than conventional hotels, while the valuation of ABNB stock remains tremendous.

Load More